Pasar al contenido principal

EL EJE SEÑALIZADOR PLK1/NEK9/NEK6/7 EN G2 Y MITOSIS TEMPRANA

PID2021-127045NB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

BICD2 phosphorylation regulates dynein function and centrosome separation in G2 and M

  • Gallisà-Suñé, Núria
  • Sànchez-Fernàndez de Landa, Paula
  • Zimmermann, Fabian
  • Serna, Marina
  • Regué, Laura
  • Paz, Joel
  • Llorca, Óscar
  • Lüders, Jens
  • Roig, Joan
The activity of dynein is regulated by a number of adaptors that mediate its interaction with dynactin, effectively activating the motor complex while also connecting it to different cargos. The regulation of adaptors is consequently central to dynein physiology but remains largely unexplored. We now describe that one of the best-known dynein adaptors, BICD2, is effectively activated through phosphorylation. In G2, phosphorylation of BICD2 by CDK1 promotes its interaction with PLK1. In turn, PLK1 phosphorylation of a single residue in the N-terminus of BICD2 results in a structural change that facilitates the interaction with dynein and dynactin, allowing the formation of active motor complexes. Moreover, modified BICD2 preferentially interacts with the nucleoporin RanBP2 once RanBP2 has been phosphorylated by CDK1. BICD2 phosphorylation is central for dynein recruitment to the nuclear envelope, centrosome tethering to the nucleus and centrosome separation in the G2 and M phases of the cell cycle. This work reveals adaptor activation through phosphorylation as crucial for the spatiotemporal regulation of dynein activity., J.R. and N.G.-S.work was funded by the Ministerio de Ciencia e Innovación (MICINN) and the Agencia Estatal de Investigación (AEI) from Spain (MCIN/ AEI /10.13039/501100011033/ FEDER “Una manera de hacer Europa”) through Plan Nacional de I + D grants BFU2014-58422-P, PGC2018-096307-B-I00 and PID2021-127045NB-I00 (to J.R.) and by network grant 2017 SGR 1089 (AGAUR, Generalitat de Catalunya). N.G.-S. was a recipient of FPI Fellowship BES-2015-072446 from MICINN. Work in the laboratory of J.L. was supported by grants BFU2015-69275-P (MINECO/FEDER), PGC2018-099562-B-I00 (MICINN), network grants 2017 SGR 1089 (AGAUR) and RED2018-102723-T (MICINN), and by intramural funds of IRB Barcelona, supported by CERCA (Generalitat de Catalunya). F.Z. was supported by a fellowship from the “la Caixa” Foundation (ID 100010434, fellowship code LCF/BQ/DI17/11620020) and the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement no. 713673. J.P. was supported by a fellowship from MICINN (BES-2016-078003). O.L. and M.S. work was funded by the Agencia Estatal de Investigación (AEI/10.13039/501100011033), Ministerio de Ciencia e Innovación [PID2020-114429RB-I00] and by the Autonomous Region of Madrid, co-funded by the European Regional Development Fund (ERDF) [SAF2017-82632-P to O.L.]; Autonomous Region of Madrid and co-funded by the European Social Fund and the European Regional Development Fund [Y2018/BIO4747 and P2018/NMT4443 to O.L.]; CNIO is supported by the National Institute of Health Carlos III., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The mesenchymal morphology of cells expressing the EML4–ALK V3 oncogene is dependent on phosphorylation of Eg5 by NEK7

  • Pashley, Sarah L.
  • Papageorgiou, Savvas
  • O'Regan, Laura
  • Barone, Giancarlo
  • Robinson, Susan W.
  • Lucken, Kellie
  • Straatman, Kees R.
  • Roig, Joan
  • Fry, Andrew M.
Echinoderm microtubule-associated protein-like 4 (EML4)–anaplastic lymphoma kinase (ALK) oncogenic fusion proteins are found in approximately 5% of non–small cell lung cancers. Different EML4–ALK fusion variants exist with variant 3 (V3) being associated with a significantly higher risk than other common variants, such as variant 1 (V1). Patients with V3 respond less well to targeted ALK inhibitors, have accelerated rates of metastasis, and have poorer overall survival. A pathway has been described downstream of EML4–ALK V3 that is independent of ALK catalytic activity but dependent on the NEK9 and NEK7 kinases. It has been proposed that assembly of an EML4–ALK V3–NEK9–NEK7 complex on microtubules leads to cells developing a mesenchymal-like morphology and exhibiting enhanced migration. However, downstream targets of this complex remain unknown. Here, we show that the microtubule-based kinesin, Eg5, is recruited to interphase microtubules in cells expressing EML4–ALK V3, whereas chemical inhibition of Eg5 reverses the mesenchymal morphology of cells. Furthermore, we show that depletion of NEK7 interferes with Eg5 recruitment to microtubules in cells expressing EML4–ALK V3 and cell length is reduced, but this is reversed by coexpression of a phosphomimetic mutant of Eg5, in a site, S1033, phosphorylated by NEK7. Intriguingly, we also found that expression of Eg5-S1033D led to cells expressing EML4–ALK V1 adopting a more mesenchymal-like morphology. Together, we propose that Eg5 acts as a substrate of NEK7 in cells expressing EML4–ALK V3 and Eg5 phosphorylation promotes the mesenchymal morphology typical of these cells., We thank the University of Leicester Core Biotechnology Services for providing access to the Advanced Imaging Facility (Research Resource Identifier: SCR_020967) and the Biotechnology and Biological Sciences Research Council for providing funding for the Zeiss Airyscan microscope (grant no.: BB/S019510/1 ). We are grateful to Jene Choi (Asan Medical Centre, Seoul) for providing BEAS-2B cells expressing EML4-ALK V1 and V3., Peer reviewed